Search Results

of the most prestigious Clinician Postdoctoral Fellowships offered by Alberta Innovates and Canadian Institutes of Health Research. Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined In her time as an undergraduate, Maddi was a researcher in Dr. From there, she went on to be a research technologist in Dr.

Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Fellow at the Institute of Metabolism and Systems Research (IMSR) of the University of Birmingham and Between 2009 and 2017, he was a Group Leader at the Institute of Pharmacology and Toxicology and Rudolf He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and

co-founders of GeneMode, on the ten billion dollars American labs waste every year — and why rebuilding research Most scientific research still runs on infrastructure built for a different century. He trained as a bioengineer and worked as a research scientist in stem cell and cancer labs before founding Excel is the default research tool because no one built a better one for scientists. scientists to make research more efficient.

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors Shivani Sachdev on the web NIDDK ReseachGate Google Scholar LinkedIn Twitter Dr.

in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute After my Ph.D. defense in 2019, I moved with a DFG (German research council) PostDoc fellowship to Stockholm , Sweden, in order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute. Hannes Schihada on the web Karolinska Institutet Twitter Adher´n Rise LinkedIn Dr.

In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist Nariman Balenga on the web Researchgate Linkedin.com Google Scholar Dr.

metabotropic glutamate and muscarinic receptors - before completing postdoctoral training at the National Institute The results have not been released to the research community. training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol Abuse and Alcoholism. Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

Guenter Blobel , before starting my Ph.D. in 2009 at The Scripps Research Institute in La Jolla. Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology

He is the Research director at INSERM with a specific interest in G protein-coupled receptors by developing His laboratory is currently located at the Institute Cochin – Inserm (Paris, France). He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research receptor » sub-committee, Editor-in-Chief of « Frontiers in Cellular Endocrinology » and AE of « J Pineal Research He is a highly cited researcher – 2019 and 2020 identified by Clarivate Web of Science ™. Dr.

GPCRs are among the most powerful and complex targets in biomedical research. She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. In 2020, together with her team, she initiated a long-term research effort that enabled the creation Eric Trinquet, Director of Research and Development at Revvity.

Addiction, a multidisciplinary initiative within the University of Minnesota’s Medical School to advance research Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate Slosky’s work has been recognized through several travel and research awards, including the William James In addition to research, Dr. Program and is working to build relationships with key stakeholders through institutional and community

He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training GPCRs while training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute.

Her current research asks how the regulatory proteins that most GPCR pharmacologists have not yet addressed About the Guest Elva Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS Her current research integrates both frameworks - examining how the GLP-1 receptor engages its transducer Zhao describes how the objective of biased agonism research at the GLP-1 receptor is to develop ligand About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Sciences

Prasenjit Saha I conducted my doctoral research at the Indian Institute of Science, Bangalore, India, My research goal is to identify novel cellular target receptors of human gut microbe-derived metabolites During my post-doctoral research, I was part of a study that identified the receptors of a novel human My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs.

Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer Trejo’s research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation , and cancer and is an important drug target. San Diego Trejo Lab Wikipedia LinkedIn Google Scholar Orcid Twitter UC San Diego School of Medicine Researchgate

Insights for GPCR researchers and functional assay innovators. << Back to podcast list Strategic Partner Laura Duvall, whose research tracks the molecular mechanisms that govern mosquito behavior, focusing This episode is essential for anyone advancing GPCR-targeted research in physiological or behavioral As a postdoctoral researcher in Leslie Vosshall’s laboratory at Rockefeller University, Dr. at Columbia University, where she is part of the Department of Biological Sciences and the Zuckerman Institute

His research spans BRET-based assay platforms for characterizing signaling downstream of specific GPCRs Scientific Themes of the Conversation Lab continuity during institutional shutdown — What it takes to Pandemic preparedness as a scientific failure — The gap between what infectious disease researchers had been warning about and what institutions were actually ready to do. The failure wasn't epistemic — it was institutional.

But for the researcher who first encountered it not as a theory but as an anomalous bell-shaped dose-response Pharmacology within the Discovery and Optimization organization at Bristol-Myers Squibb, where he leads research work on circadian regulation of prolactin secretion at Florida State University before postdoctoral research His early work at Wyeth's Women's Health Research Institute produced foundational observations on biased physiologist's approach to mechanistic drug discovery The erosion of pharmacology training in pharmaceutical research

Research, 2014) and GPCRs (Feigin, et al., PNAS, 2014) in breast cancer pathogenesis, using mouse models They also discussed his research on cell polarity and its role in cancer progression, his work on G-protein Mike's Research on Cell Polarity and GPCRs in Cancer Mike shared his research on cell polarity and its GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted GPCRs and Cancer Immune Modulation Yamina and Mike had a discussion about their research on GPCRs, specifically

His doctoral research focused on the structural and functional characterization of bitter taste receptors Jurgen Wess’s lab at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) - NIH, Sai Prasad Pydi on the web Molecular Metabolism & Cell Signaling Laboratory Website Twitter.com Research

a molecular pharmacologist at the University of Nottingham, to discuss his scientific journey, GPCR research Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor research Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions In 2010 he became a group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing

While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Institute After moving to Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced and Ping Chi , that a mutant of CYSLTR2 is a driver oncogene in uveal melanoma, the most common eye cancer The CysLTR2 oncoprotein displays biased constitutive activity – it activates Gq/11 but does not undergo Sakmar on the web LinkedIn ResearchGate Pubmed ORCHID Google Scholar Rockefeller University Wikipedia

Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). He has published over 70 research articles, reviews and book chapters on drug discovery, which have been

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated

highlights the role of interdisciplinary collaboration in accelerating innovation in diabetes and obesity research Originally trained as a Veterinary Surgeon , he completed postdoctoral research at the CNRS in Montpellier He later served as Professor of Cellular Metabolism and Institute Deputy Director at the University of

He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging supervision of Michel Bouvier at Université de Montréal, followed by a Postdoctoral Fellow at Scripps Research

Besides research, I am passionate about teaching, science communication and making research more inclusive John Janetzko on the web Stanford University Stanford Medicine Google Scholar Personal Website ResearchGate importance of adaptability, as unexpected situations like the Covid-19 pandemic can affect the job searching shared his positive experiences from job interviews and forming friendships with colleagues at various institutions